About YX Genomics Holding
YX Genomics Holding is a company based in Memphis (United States) founded in 2013 by Bob Bean was acquired by Thompson Street Capital Partners in March 2018.. YX Genomics Holding operates in a competitive market with competitors including Biocytogen, Rejuvenate Bio, Interius Biotherapeutics, Novogene Corporation and Applied StemCell, among others.
- Headquarter Memphis, United States
- Founders Bob Bean
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Thompson Street Capital Partners
(Mar 27, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of YX Genomics Holding
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in YX Genomics Holding
YX Genomics Holding has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Thompson Street Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity firm focused on middle-market business investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by YX Genomics Holding
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - YX Genomics Holding
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Yx Genomics Holding Comparisons
Competitors of YX Genomics Holding
YX Genomics Holding operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Rejuvenate Bio, Interius Biotherapeutics, Novogene Corporation and Applied StemCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| domain | founded_year | HQ Location |
Meta-genomics platforms and services for microbiome studies are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about YX Genomics Holding
When was YX Genomics Holding founded?
YX Genomics Holding was founded in 2013.
Where is YX Genomics Holding located?
YX Genomics Holding is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
What does YX Genomics Holding do?
YX Genomics Holding was established in 2013 in Memphis, United States, within the biotechnology sector. Genotyping services for transgenic, knockout, and knock-in mouse lines are delivered through its subsidiary TransnetYX. Laboratory setup and operations management for diagnostic labs are handled by YX Services, while custom robotic solutions for molecular applications are developed by RobotYX. The companys laboratory holds CLIA certification and CAP accreditation.
Who are the top competitors of YX Genomics Holding?
YX Genomics Holding's top competitors include Biocytogen, Novogene Corporation and BGI.
Who are YX Genomics Holding's investors?
YX Genomics Holding has 1 investor. Key investors include Thompson Street Capital Partners.